155 related articles for article (PubMed ID: 36674564)
1. Transcripts of the Prostate Cancer-Associated Gene
Metsälä O; Wahlström G; Taimen P; Kellokumpu-Lehtinen PL; Schleutker J
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674564
[TBL] [Abstract][Full Text] [Related]
2. Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancer.
Marx A; Koopmann L; Höflmayer D; Büscheck F; Hube-Magg C; Steurer S; Eichenauer T; Clauditz TS; Wilczak W; Simon R; Sauter G; Izbicki JR; Huland H; Heinzer H; Graefen M; Haese A; Schlomm T; Bernreuther C; Lebok P; Bonk S
Cancer Biol Med; 2021 Feb; 18(1):245-255. PubMed ID: 33628598
[TBL] [Abstract][Full Text] [Related]
3. The variant rs77559646 associated with aggressive prostate cancer disrupts ANO7 mRNA splicing and protein expression.
Wahlström G; Heron S; Knuuttila M; Kaikkonen E; Tulonen N; Metsälä O; Löf C; Ettala O; Boström PJ; Taimen P; Poutanen M; Schleutker J
Hum Mol Genet; 2022 Jun; 31(12):2063-2077. PubMed ID: 35043958
[TBL] [Abstract][Full Text] [Related]
4. The interactome of the prostate-specific protein Anoctamin 7.
Kaikkonen E; Takala A; Pursiheimo JP; Wahlström G; Schleutker J
Cancer Biomark; 2020; 28(1):91-100. PubMed ID: 32176628
[TBL] [Abstract][Full Text] [Related]
5. ANO7: Insights into topology, function, and potential applications as a biomarker and immunotherapy target.
Guo J; Wang D; Dong Y; Gao X; Tong H; Liu W; Zhang L; Sun M
Tissue Cell; 2021 Oct; 72():101546. PubMed ID: 33940566
[TBL] [Abstract][Full Text] [Related]
6. ANO7 is associated with aggressive prostate cancer.
Kaikkonen E; Rantapero T; Zhang Q; Taimen P; Laitinen V; Kallajoki M; Jambulingam D; Ettala O; Knaapila J; Boström PJ; Wahlström G; Sipeky C; Pursiheimo JP; Tammela T; Kellokumpu-Lehtinen PL; ; Fey V; Maehle L; Wiklund F; Wei GH; Schleutker J
Int J Cancer; 2018 Nov; 143(10):2479-2487. PubMed ID: 30157291
[TBL] [Abstract][Full Text] [Related]
7. Global expression of AMACR transcripts predicts risk for prostate cancer - a systematic comparison of AMACR protein and mRNA expression in cancerous and noncancerous prostate.
Alinezhad S; Väänänen RM; Ochoa NT; Vertosick EA; Bjartell A; Boström PJ; Taimen P; Pettersson K
BMC Urol; 2016 Feb; 16():10. PubMed ID: 26928323
[TBL] [Abstract][Full Text] [Related]
8. Expression of a human cell adhesion molecule, MUC18, in prostate cancer cell lines and tissues.
Wu GJ; Varma VA; Wu MW; Wang SW; Qu P; Yang H; Petros JA; Lim SD; Amin MB
Prostate; 2001 Sep; 48(4):305-15. PubMed ID: 11536311
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression.
Wu GJ; Wu MW; Wang SW; Liu Z; Qu P; Peng Q; Yang H; Varma VA; Sun QC; Petros JA; Lim SD; Amin MB
Gene; 2001 Nov; 279(1):17-31. PubMed ID: 11722842
[TBL] [Abstract][Full Text] [Related]
10. Genetic association analysis identifies a role for ANO5 in prostate cancer progression.
Yu CC; Chen LC; Huang CY; Lin VC; Lu TL; Lee CH; Huang SP; Bao BY
Cancer Med; 2020 Apr; 9(7):2372-2378. PubMed ID: 32027096
[TBL] [Abstract][Full Text] [Related]
11. Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression.
Debiais-Delpech C; Godet J; Pedretti N; Bernard FX; Irani J; Cathelineau X; Cussenot O; Fromont G
Urol Oncol; 2014 May; 32(4):426-32. PubMed ID: 24332637
[TBL] [Abstract][Full Text] [Related]
12. CXXC5 expression in prostate cancer: implications for cancer progression.
Benedetti I; De Marzo AM; Geliebter J; Reyes N
Int J Exp Pathol; 2017 Aug; 98(4):234-243. PubMed ID: 29027288
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor (IGF)-I, IGF-II and IGF type I receptor (IGFR-I) expression in prostatic cancer.
Cardillo MR; Monti S; Di Silverio F; Gentile V; Sciarra F; Toscano V
Anticancer Res; 2003; 23(5A):3825-35. PubMed ID: 14666684
[TBL] [Abstract][Full Text] [Related]
14. Calcitonin is a prostate epithelium-derived growth stimulatory peptide.
Chien J; Ren Y; Qing Wang Y; Bordelon W; Thompson E; Davis R; Rayford W; Shah G
Mol Cell Endocrinol; 2001 Jul; 181(1-2):69-79. PubMed ID: 11476942
[TBL] [Abstract][Full Text] [Related]
15. Enhanced expression of SOS1 is detected in prostate cancer epithelial cells from African-American men.
Timofeeva OA; Zhang X; Ressom HW; Varghese RS; Kallakury BV; Wang K; Ji Y; Cheema A; Jung M; Brown ML; Rhim JS; Dritschilo A
Int J Oncol; 2009 Oct; 35(4):751-60. PubMed ID: 19724911
[TBL] [Abstract][Full Text] [Related]
16. ANO7 African-ancestral genomic diversity and advanced prostate cancer.
Jiang J; Soh PXY; Mutambirwa SBA; Bornman MSR; Haiman CA; Hayes VM; Jaratlerdsiri W
Prostate Cancer Prostatic Dis; 2023 Sep; ():. PubMed ID: 37749167
[TBL] [Abstract][Full Text] [Related]
17. HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected androgen-dependent and androgen-independent cancer.
Montironi R; Mazzucchelli R; Barbisan F; Stramazzotti D; Santinelli A; Scarpelli M; Lòpez Beltran A
Hum Pathol; 2006 Sep; 37(9):1137-44. PubMed ID: 16938518
[TBL] [Abstract][Full Text] [Related]
18. Expression of anoctamin 7 (ANO7) is associated with poor prognosis and mucin 2 (MUC2) in colon adenocarcinoma: a study based on TCGA data.
Chen C; Aluksanasuwan S; Somsuan K
Genomics Inform; 2023 Dec; 21(4):e46. PubMed ID: 38224713
[TBL] [Abstract][Full Text] [Related]
19. Expression of tSTAT3, pSTAT3
Krzyzanowska A; Don-Doncow N; Marginean FE; Gaber A; Watson RW; Hellsten R; Bjartell A
Prostate; 2019 May; 79(7):784-797. PubMed ID: 30905090
[TBL] [Abstract][Full Text] [Related]
20. Expression of Peroxisome Proliferator Activated Receptor gamma in Prostatic Adenocarcinoma.
Park HK; Kim H; Kim HG; Cho YM; Jung WY; Han HS; Hwang TS; Kwon GY; Lim SD
J Korean Med Sci; 2015 May; 30(5):533-41. PubMed ID: 25931782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
